P1107: CLINICAL OUTCOMES OF SOLID ORGAN TRANSPLANT PATIENTS WITH EBV+ PTLD WHO FAIL RITUXIMAB PLUS CHEMOTHERAPY: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY

• V. Dharnidharka,
• D. Thirumalai,
• U. Jaeger,
• W. Zhao,
• D. Dierickx,
• P. Xun,
• P. Minga,
• A. Sawas,
• N. Sadetsky,
• P. Chauvet,
• E. Sundaram,
• A. Barlev,
• H. Zimmerman,
• R. U. Trappe

Affiliations

V. Dharnidharka

1 Washington University School of Medicine & St. Louis Children’s Hospital, St Louis

D. Thirumalai

2 Atara Biotherapeutics, Thousand Oaks, United States of America

U. Jaeger

3 Medical University of Vienna, Vienna, Austria

W. Zhao

2 Atara Biotherapeutics, Thousand Oaks, United States of America

D. Dierickx

4 Universitair Ziekenhuis Leuven, Leuven, Belgium

P. Xun

2 Atara Biotherapeutics, Thousand Oaks, United States of America

P. Minga

5 Niguarda Ca’ Granda Hospital, Milan, Italy

A. Sawas

6 Herbert Irving Comprehensive Cancer Center, New York

N. Sadetsky

7 Atara Biotherapeutics, South San Francisco, United States of America

P. Chauvet

8 CHU Lille, Lille, France

E. Sundaram

9 Nashville Bioscences, Nashville, United States of America

A. Barlev

7 Atara Biotherapeutics, South San Francisco, United States of America

H. Zimmerman

10 DIAKO Bremen, Bremen, Germany

R. U. Trappe

10 DIAKO Bremen, Bremen, Germany